Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology [Internet]. 2008;134:1715–1728

PubMed  Google Scholar 

Chung C, Iwakiri Y. The lymphatic vascular system in liver diseases: its role in ascites formation. Clin Mol Hepatol [Internet]. 2013;19:99

PubMed  Google Scholar 

Burchill MA, Goldberg AR, Tamburini BAJ. Emerging roles for lymphatics in chronic liver disease. Front Physiol. 2020;10:1579

PubMed  PubMed Central  Google Scholar 

Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis—current status and future directions. J Hepatol [Internet]. 2014;61:912–924

CAS  PubMed  Google Scholar 

Petrova TV, Koh GY. Biological functions of lymphatic vessels. Science [Internet] 2020;369. https://pubmed.ncbi.nlm.nih.gov/32646971/(cited 2021 Aug 14)

Lee Y, Zawieja SD, Muthuchamy M. Lymphatic collecting vessel: new perspectives on mechanisms of contractile regulation and potential lymphatic contractile pathways to target in obesity and metabolic diseases. Front Pharmacol [Internet]. 2022;13:848088

CAS  PubMed  Google Scholar 

Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic vessel network structure and physiology. Compr Physiol. 2018;9:207–299

PubMed  PubMed Central  Google Scholar 

Ohtani O, Ohtani Y. Lymph circulation in the liver. Anat Rec. 2008;291:643–652

Google Scholar 

Starling EH. Physiological factors involved in the causation of dropsy. Lancet 1896:1267–1270

Yang Y, Jeong J, Su T, Lai S, Zhang P, Garcia-Milian R, et al. Interleukin-7-based identification of liver lymphatic endothelial cells reveals their unique structural features. JHEP Rep. 2024;6:101069

PubMed  PubMed Central  Google Scholar 

Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, et al. Oxidized low-density lipoprotein drives dysfunction of the liver lymphatic system. Cell Mol Gastroenterol Hepatol. 2021;11:573–595

CAS  PubMed  Google Scholar 

Bataller R, Brenner DA. Liver fibrosis. J Clin Invest [Internet]. 2005;115:209–218

CAS  PubMed  Google Scholar 

Angus PW. Role of endothelin in systemic and portal resistance in cirrhosis. Gut [Internet]. 2006;55:1230

CAS  PubMed  Google Scholar 

Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol [Internet]. 2010;16:347

PubMed  Google Scholar 

Dumont AE, Mulholland JH. Flow rate and composition of thoracic-duct lymph in patients with cirrhosis. N Engl J Med. 2010;263:471–474. https://doi.org/10.1056/NEJM196009082631001

Article  Google Scholar 

Yamauchi Y, Michitaka K, Onji M. Morphometric analysis of lymphatic and blood vessels in human chronic viral liver diseases. Am J Pathol [Internet]. 1998;153:1131–1137

CAS  PubMed  Google Scholar 

Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, et al. Oxidized low-density lipoprotein drives dysfunction of the liver lymphatic system. Cell Mol Gastroenterol Hepatol [Internet]. 2021;11:573–595

CAS  PubMed  Google Scholar 

Yamauchi Y, Ikeda R, Michitaka K, Hiasa Y, Horiike N, Onji M, et al. Morphometric analysis of lymphatic vessels in primary biliary cirrhosis. Hepatol Res. 2002;24(2):107. https://doi.org/10.1016/s1386-6346(02)00019-0. (PMID: 12270739)

Article  PubMed  Google Scholar 

Tamburini BAJ, Finlon JM, Gillen AE, Kriss MS, Riemondy KA, Fu R, et al. Chronic liver disease in humans causes expansion and differentiation of liver lymphatic endothelial cells. Front Immunol. 2019;0:1036

Google Scholar 

Olkawa H, Masuda T, Sato SI, Yashima A, Suzuki K, Sato S, et al. Changes in lymph vessels and portal veins in the portal tract of patients with idiopathic portal hypertension: a morphometric study. Hepatology [Internet]. 1998;27:1607–1610

Google Scholar 

Zhang P, Li H, Zhou C, Liu K, Peng B, She X, et al. Single-cell RNA transcriptomics reveals the state of hepatic lymphatic endothelial cells in hepatitis B virus-related acute-on-chronic liver failure. J Clin Med [Internet]. 2022;11:2910

CAS  PubMed  Google Scholar 

Montenegro-Navarro N, García-Báez C, García-Caballero M. Molecular and metabolic orchestration of the lymphatic vasculature in physiology and pathology. Nat Commun. 2023;14:1–18

Google Scholar 

Colle I, Geerts AM, Van Steenkiste C, Van Vlierberghe H. Hemodynamic changes in splanchnic blood vessels in portal hypertension. Anat Rec Adv Integr Anat Evol Biol [Internet]. 2008;291:699–713. https://doi.org/10.1002/ar.20667

Article  Google Scholar 

Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep [Internet]. 2021;3:100316

PubMed  Google Scholar 

Barrowman JA, Granger DN. Effects of experimental cirrhosis on splanchnic microvascular fluid and solute exchange in the rat. Gastroenterology. 1984;87:165–172

CAS  PubMed  Google Scholar 

Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernández-Varo G, Held KF, et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut [Internet]. 2013;62:138–145

CAS  PubMed  Google Scholar 

Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernández-Varo G, Held KF, et al. Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut. 2013;62(1):1

Google Scholar 

Hori N, Wiest R, Groszmann RJ. Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats. Hepatology [Internet]. 1998;28:1467–1473

CAS  PubMed  Google Scholar 

Juneja P, Sharma A, Shasthry SM, Kumar G, Tripathi DM, Rajan V, et al. Podoplanin-positive dilated lymphatic vessels in duodenum associates with three-month mortality in patients with cirrhosis. Front Physiol [Internet]. 2023;14:856. https://doi.org/10.3389/fphys.2023.1045983/full

Article  Google Scholar 

Witte MH, Dumont AE, Cole WR, Witte CL, Kintner K. Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med [Internet]. 1969;70:303–310

CAS  PubMed  Google Scholar 

Verma SK, Mitchell DG, Bergin D, Lakhman Y, Austin A, Verma M, et al. Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging. Abdom Imaging [Internet]. 2009;34:211–216

PubMed  Google Scholar 

Pieper CC, Feißt A, Meyer C, Luetkens J, Praktiknjo M, Trebicka J, et al. Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis. Sci Rep [Internet] 2021;11. https://pubmed.ncbi.nlm.nih.gov/33782430/(cited 2024 Dec 26)

Yano R, Hirooka M, Koizumi Y, Nakamura Y, Imai Y, Morita M, et al. Lymphatic drainage dysfunction via narrowing of the lumen of cisterna chyli and thoracic duct after luminal dilation. Hepatol Int [Internet]. 2023;17:1557–1569

PubMed  Google Scholar 

Ma R, Iwakiri Y. Lymphatic drainage dysfunction is related to clinically significant portal hypertension. Hepatol Int [Internet]. 2023;17:1327–1330. https://doi.org/10.1007/s12072-023-10592-z

Article  PubMed  Google Scholar 

Hirooka M, Koizumi Y, Yano R, Nakamura Y, Sunago K, Yukimoto A, et al. Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites. Sci Rep. 2022;12(1):8124. https://doi.org/10.1038/s41598-

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langford RJ, Daudia AT, Malins TJ. A morphological study of the thoracic duct at the jugulo-subclavian junction. J Cranio-Maxillo-Facial Surg. 1999;27:100–104

CAS  Google Scholar 

Ghelfi J, Brusset B, Thony F, Decaens T. Successful management of refractory ascites in non-TIPSable patients using percutaneous thoracic duct stenting. J Hepatol [Internet]. 2022;76:216–218

PubMed  Google Scholar 

Ghelfi J, Brusset B, Teyssier Y, Sengel C, Gerster T, Girard E, et al. Endovascular lymphatic decompression via thoracic duct stent placement for refractory ascites in patients with cirrhosis: a pilot study. J Vasc Interv Radiol. 2023;34:212–217

Article  PubMed  Google Scholar 

Henriksen JH. Estimation of lymphatic conductance. A model based on protein-kinetic studies and haemodynamic measurements in patients with cirrhosis of the liver and in pigs. Scand J Clin Lab Investig [Internet]. 1985;45:123–130

Article  CAS  Google Scholar 

Lenz K, Buder R, Voglmayr M, Kapun L. Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol [Internet]. 2015;8:83

PubMed  Google Scholar 

Kumar R, Anand U, Priyadarshi RN. Lymphatic dysfunction in advanced cirrhosis: contextual perspective and clinical implications. World J Hepatol [Internet]. 2021;13:300

PubMed  Google Scholar 

Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl Hepatol [Internet]. 2017;6:105

PubMed  Google Scholar 

Kumar R, Kumar T, Anand U, Priyadarshi RN. Intestinal lymphangiectasia associated with refractory ascites in a cirrhosis patient. Cureus [Internet] 2021;13. https://pubmed.ncbi.nlm.nih.gov/33564554/(cited 2024 Feb 9)

Deitch EA, Adams CA, Lu Q, Xu DZ. Mesenteric lymph from rats subjected to trauma-hemorrhagic shock are injurious to rat pulmonary microvascular endothelial cells as well as human umbilical